Literature DB >> 27107624

Chemical vs Surgical ADT in Metastatic Prostate Cancer: A Comparison of Side Effects. Commentary on Comparison of Gonadotropin-releasing Hormone Agonists and Orchiectomy: Effects of Androgen Deprivation Therapy.

Brandon Van Asseldonk1, Peter Black2, Dean S Elterman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27107624     DOI： 10.1016/j.urology.2016.04.002

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  4 in total

1.  Effect on bone mineral density in surgical versus medical castration for metastatic prostate cancer.

Authors:  Mohamed Sharafeldeen; Mohamed Elsaqa; Wael Sameh; Ahmed Elabbady
Journal:  Turk J Urol       Date:  2021-03-01

2.  Melatonin decreases androgen-sensitive prostate cancer growth by suppressing SENP1 expression.

Authors:  Lin Hao; Yang Dong; Jun-Jie Zhang; Cong-Hui Han; Zhen-Duo Shi; Hou-Guang He; Jian-Gang Chen; Shao-Qi Zhang; Qian-Jin Zhang; Wei Wu
Journal:  Transl Androl Urol       Date:  2022-01

3.  Significant financial differences of chemical and surgical androgen deprivation in a contemporary cohort.

Authors:  Charles J Paul; Rohan Garje; Karl J Kreder; Sarah L Mott; Paul T Gellhaus
Journal:  Transl Androl Urol       Date:  2022-09

4.  Is there still a role for bilateral orchidectomy in androgen-deprivation therapy for metastatic prostate cancer?

Authors:  Mohamed Adel Atta; Ahmed Elabbady; Wael Sameh; Mohamed Sharafeldeen; Mohamed Elsaqa
Journal:  Arab J Urol       Date:  2019-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.